Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis

被引:32
作者
Montella, Liliana [1 ]
Merola, Carmela
Merola, Geraldina [2 ]
Petillo, Luigi [2 ]
Palmieri, Giovannella [2 ]
机构
[1] S Giovanni Dio Hosp, Med Oncol Unit, Naples, Italy
[2] Univ Naples Federico 2, Mol & Clin Endocrinol & Oncol Dept, Naples, Italy
关键词
Langerhans cell histiocytosis; Bone lesions; Zoledronic acid; BISPHOSPHONATES; PAMIDRONATE;
D O I
10.1007/s00774-008-0001-2
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Langerhans cell histiocytosis (LCH) is a rare disease, probably an atypical myeloproliferative syndrome, with variable clinical presentation and behavior. In this report, we focus on bone involvement by LCH and treatment with zoledronic acid in six patients as they progressed after chemotherapy and radiotherapy. Zoledronic acid appeared safe and produced significant relief in pain.
引用
收藏
页码:110 / 113
页数:4
相关论文
共 13 条
[1]
ARCECI RJ, 2002, HEMATOL-AM SOC HEMAT, V1, P297
[2]
Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis [J].
Arzoo, K ;
Sadeghi, S ;
Pullarkat, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :225-225
[3]
Baumgartner I, 1997, MED PEDIATR ONCOL, V28, P9, DOI 10.1002/(SICI)1096-911X(199701)28:1<9::AID-MPO3>3.0.CO
[4]
2-P
[5]
Bisphosphonates: Clinical experience [J].
Coleman, RE .
ONCOLOGIST, 2004, 9 :14-27
[6]
DEMARCOS JAG, 2007, MED ORAL PATOL ORAL, V12, pE145
[7]
Egeler RM, 1999, BLOOD, V94, P4195
[8]
Treatment of Langerhans cell histiocytosis with pamidronate [J].
Farran, RP ;
Zaretski, E ;
Egeler, RM .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (01) :54-56
[9]
A randomized trial of treatment for multisystem Langerhans' cell histiocytosis [J].
Gadner, H ;
Grois, N ;
Arico, M ;
Broadbent, V ;
Ceci, A ;
Jakobson, A ;
Komp, D ;
Michaelis, J ;
Nicholson, S ;
Pölschger, U ;
Pritchard, J ;
Ladisch, S .
JOURNAL OF PEDIATRICS, 2001, 138 (05) :728-734
[10]
Bisphosphonates: Preclinical review [J].
Green, JR .
ONCOLOGIST, 2004, 9 :3-13